Kevin P. Starr, Director at Sage Therapeutics, Inc. (SAGE), bought 35,684 shares at $56.05 ($2.0M) on 2021-06-16, disclosed to the SEC on 2021-06-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $56.05 | 17,842 | $1.0M | 50.0% |
| 2 | $56.05 | 17,842 | $1.0M | 50.0% |
| Total | $56.05 avg | 35,684 | $2.0M | 100% |
| Filing → |
| SAGE | SELL | 2018-04-19 | $10.0M | — | Filing → |
| MYOK | SELL | 2018-01-05 | $34.3M | — | Filing → |
| MYOK | SELL | 2017-10-04 | $6.1M | — | Filing → |